84. サルコイドーシス Sarcoidosis Clinical trials / Disease details

臨床試験数 : 149 / 薬物数 : 227 - (DrugBank : 81) / 標的遺伝子数 : 82 - 標的パスウェイ数 : 167

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03793439 (ClinicalTrials.gov)	May 15, 2019	2/1/2019	Tofacitinib Hypothesis-generating, Pilot Study for Corticosteroid-Dependent Sarcoidosis	Tofacitinib Hypothesis-generating, Pilot Study for Corticosteroid-Dependent Sarcoidosis	Sarcoidosis, Pulmonary;Sarcoidosis Lung;Sarcoidosis	Drug: Tofacitinib 5mg Oral Tablet [Xeljanz] 16 week trial;Diagnostic Test: Spirometry;Genetic: RNA Se ...	Oregon Health and Science University	Pfizer	Recruiting	18 Years	89 Years	All	5	Phase 1	United States
2	NCT03910543 (ClinicalTrials.gov)	April 11, 2019	4/4/2019	Open-label Trial of Tofacitinib in Cutaneous Sarcoidosis and Granuloma Annulare	Open-label Trial of Tofacitinib in Cutaneous Sarcoidosis and Granuloma Annulare	Cutaneous Sarcoidosis;Granuloma Annulare	Drug: Tofacitinib 5 mg twice daily	Yale University	Pfizer	Completed	18 Years	N/A	All	15	Phase 1	United States

First Previous1Next Last